IDEXX's (IDXX) CAG Diagnostic Sales Gain, Cost Woe Stays

Published on February 8, 2022

IDEXX (IDXX) witnesses continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.

Continue reading on website
Other news

Here's Why You Should Retain Nevro (NVRO) Stock For Now

February 8, 2022
Investors continue to be optimistic about Nevro (NVRO) owing to its strength in the global SCS market.

What's in the Offing for Mettler-Toledo's (MTD) Q4 Earnings?

February 8, 2022
Mettler-Toledo's (MTD) fourth-quarter results are likely to reflect benefits of strong momentum across the laboratory and industrial businesses amid the coronavirus-induced headwinds.